Kovacheva E, Gevezova M, Mehterov N, Kazakova M, Sarafian V
Int J Mol Sci. 2025; 26(5).
PMID: 40076836
PMC: 11899999.
DOI: 10.3390/ijms26052217.
Yashooa R, Duranti E, Conconi D, Lavitrano M, Mustafa S, Villa C
Int J Mol Sci. 2025; 26(2).
PMID: 39859339
PMC: 11766038.
DOI: 10.3390/ijms26020626.
Li Y, Zhang Y, He X, Guo Z, Yang N, Bai G
Metabolites. 2024; 14(12).
PMID: 39728492
PMC: 11677534.
DOI: 10.3390/metabo14120711.
Shaheen N, Shaheen A, Osama M, Nashwan A, Bharmauria V, Flouty O
NPJ Parkinsons Dis. 2024; 10(1):186.
PMID: 39369002
PMC: 11455891.
DOI: 10.1038/s41531-024-00791-2.
El Din Moawad M, Serag I, Alkhawaldeh I, Abbas A, Sharaf A, Alsalah S
Mol Neurobiol. 2024; .
PMID: 39254911
DOI: 10.1007/s12035-024-04468-y.
Stress-Related Roles of Exosomes and Exosomal miRNAs in Common Neuropsychiatric Disorders.
Chamakioti M, Chrousos G, Kassi E, Vlachakis D, Yapijakis C
Int J Mol Sci. 2024; 25(15).
PMID: 39125827
PMC: 11311345.
DOI: 10.3390/ijms25158256.
miR-218-5p and doxorubicin combination enhances anticancer activity in breast cancer cells through Parkin-dependent mitophagy inhibition.
Naso F, Bruqi K, Manzini V, Chiurchiu V, DOnofrio M, Arisi I
Cell Death Discov. 2024; 10(1):149.
PMID: 38514650
PMC: 10957887.
DOI: 10.1038/s41420-024-01914-7.
Parkin-Mediated Mitophagy by TGF-β Is Connected with Hepatic Stellate Cell Activation.
Lee J, Kim K, Jung E, Lee H, Yang J, Cho S
Int J Mol Sci. 2023; 24(19).
PMID: 37834275
PMC: 10573240.
DOI: 10.3390/ijms241914826.
Study on the Role of Mitophagy Receptor PHB2 in Doubly Uniparental Inheritance of Hyriopsis cumingii.
Wang Y, Zhu X, Gu Y, Liu Z, Mao Y, Liu X
Mar Biotechnol (NY). 2023; 25(5):790-799.
PMID: 37594541
DOI: 10.1007/s10126-023-10240-5.
A Glance at Biogenesis and Functionality of MicroRNAs and Their Role in the Neuropathogenesis of Parkinson's Disease.
Szelagowski A, Kozakiewicz M
Oxid Med Cell Longev. 2023; 2023:7759053.
PMID: 37333462
PMC: 10270766.
DOI: 10.1155/2023/7759053.
Mitochondria in Huntington's disease: implications in pathogenesis and mitochondrial-targeted therapeutic strategies.
Jurcau A, Jurcau C
Neural Regen Res. 2022; 18(7):1472-1477.
PMID: 36571344
PMC: 10075114.
DOI: 10.4103/1673-5374.360289.
Pathological and Therapeutic Advances in Parkinson's Disease: Mitochondria in the Interplay.
Naren P, Cholkar A, Kamble S, Samim Khan S, Srivastava S, Madan J
J Alzheimers Dis. 2022; 94(s1):S399-S428.
PMID: 36093711
PMC: 10473111.
DOI: 10.3233/JAD-220682.
Mitochondrial Genetic and Epigenetic Regulations in Cancer: Therapeutic Potential.
Wagner A, Kosnacova H, Chovanec M, Jurkovicova D
Int J Mol Sci. 2022; 23(14).
PMID: 35887244
PMC: 9321253.
DOI: 10.3390/ijms23147897.
Understanding the Involvement of microRNAs in Mitochondrial Dysfunction and Their Role as Potential Biomarkers and Therapeutic Targets in Parkinson's Disease.
Tryphena K, Anuradha U, Kumar R, Rajan S, Srivastava S, Singh S
J Alzheimers Dis. 2022; 94(s1):S187-S202.
PMID: 35848027
PMC: 10473154.
DOI: 10.3233/JAD-220449.
Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases.
Gentile G, Morello G, La Cognata V, Guarnaccia M, Conforti F, Cavallaro S
J Pers Med. 2022; 12(5).
PMID: 35629192
PMC: 9143965.
DOI: 10.3390/jpm12050770.
Does the Expression and Epigenetics of Genes Involved in Monogenic Forms of Parkinson's Disease Influence Sporadic Forms?.
Lanore A, Lesage S, Mariani L, Menon P, Ravassard P, Cheval H
Genes (Basel). 2022; 13(3).
PMID: 35328033
PMC: 8951612.
DOI: 10.3390/genes13030479.
Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria.
Gowda P, Reddy P, Kumar S
Ageing Res Rev. 2021; 73:101529.
PMID: 34813976
PMC: 8692431.
DOI: 10.1016/j.arr.2021.101529.
Plasma hsa-mir-19b is a potential LevoDopa therapy marker.
Chis A, Moatar A, Dijmarescu C, Rosca C, Vorovenci R, Krabbendam I
J Cell Mol Med. 2021; 25(18):8715-8724.
PMID: 34328686
PMC: 8435426.
DOI: 10.1111/jcmm.16827.
MicroRNA Dysregulation in Parkinson's Disease: A Narrative Review.
Nies Y, Mohamad Najib N, Lim W, Kamaruzzaman M, Yahaya M, Teoh S
Front Neurosci. 2021; 15:660379.
PMID: 33994934
PMC: 8121453.
DOI: 10.3389/fnins.2021.660379.
Molecular Regulation in Dopaminergic Neuron Development. Cues to Unveil Molecular Pathogenesis and Pharmacological Targets of Neurodegeneration.
Volpicelli F, Perrone-Capano C, Carlo Bellenchi G, Colucci-DAmato L, di Porzio U
Int J Mol Sci. 2020; 21(11).
PMID: 32503161
PMC: 7312927.
DOI: 10.3390/ijms21113995.